title: Pharmaceutical market access in emerging markets: concepts, components, and future.
abstract: This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets. Market access has gained considerable attention worldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown. This has resulted in governments adopting stricter measures for new product approval. Thus, pharmaceutical companies are finding it increasingly difficult to successfully address the specific challenges posed by various government and regulatory agencies and stakeholders. There is an increasing need to establish market access functions, especially in emerging markets, where the complex, dynamic healthcare landscape confounds product approval and uptake. Moreover, emerging markets are the engines of growth today, and, thus, performing in these markets is critical for the majority of pharmaceutical companies. To address the challenges posed by regulatory agencies and diverse stakeholders, a customized market access strategy is the need of the hour. A market access framework with specific tools and tactics will help companies to plan, implement, and monitor stakeholder engagement activities.
authors.affiliation: phamax Analytical Resource Pvt. Ltd., Bangalore, India.
authors.forename: Anuj
authors.initials: A
authors.lastname: Kumar
authors.affiliation: phamax Analytical Resource Pvt. Ltd., Bangalore, India.
authors.forename: Karthaveerya
authors.initials: K
authors.lastname: Juluru
authors.affiliation: phamax Analytical Resource Pvt. Ltd., Bangalore, India.
authors.forename: Phani Kishore
authors.initials: PK
authors.lastname: Thimmaraju
authors.affiliation: phamax Analytical Resource Pvt. Ltd., Bangalore, India.
authors.forename: Jayachandra
authors.initials: J
authors.lastname: Reddy
authors.affiliation: phamax Analytical Resource Pvt. Ltd., Bangalore, India.
authors.forename: Anand
authors.initials: A
authors.lastname: Patil
keywords: developed markets; emerging markets; escalating healthcare cost; market access framework; pharmaceutical market access; pricing and reimbursement; stakeholders